PHARMACIST ASSESSMENT OF THE VALUE OF PROVIDING PHARMACEUTICAL CARE IN THE COMMUNITY PHARMACY SETTING
Author(s)
Wade WE, Spruill WJ, Longe RL, Taylor TA, Burke SI, University of Georgia, Athens, GA, USA
OBJECTIVE: The first study objective was to anonymously measure the value community pharmacist research network members placed on the following pharmaceutical care services: patient counseling, patient education on disease self management, and disease screening and detection. The second objective was to assess the value these pharmacists placed on providing pharmaceutical care to patients with ten specific disease states. METHODS: Sixty community pharmacists were mailed a questionnaire asking them to rank on a scale of 1 to 10 (1 = no value; 10 = high value) their perceived “value” of providing pharmaceutical care in the areas of patient counseling as defined by OBRA regulations, education on disease self management, and disease screening and detection. They were also asked the perceived “value” of providing pharmaceutical care in ten disease areas. In order to avoid surveyor bias, no specific definition of “value” was given. RESULTS: Thirty-eight pharmacists (63.3%) completed questionnaires. The average scores were as follows: patient counseling 7.08 + 1.82, self management 7.62 + 1.46, and disease screening and detection 6.94 + 1.95. The average score for all disease areas was 7.36 + 1.81, with a range of 5.89 to 8.18. Rank order values for the 10 disease areas were as follows: diabetes 8.18 + 1.67, asthma 8.00 + 1.59, hypertension 7.95 + 1.89, disorders requiring anticoagulation 7.50 + 1.27, hypercholesterolemia 7.37 + 1.75, peptic ulcer disease 6.74 + 1.90, congestive heart failure 6.68 + 1.82, gastroesophageal reflux disease 6.68 + 1.88, prevention of menopause complications 6.63 + 1.88, and flu vaccine administration 5.89 + 2.40. CONCLUSIONS: Pharmacists placed a high value on the provision of the three evaluated pharmaceutical care services. Additionally, pharmacists recognized significant benefit in the provision of pharmaceutical care for specific disease states.
Conference/Value in Health Info
1999-05, ISPOR 1999, Arlington, VA, USA
Value in Health, Vol. 2, No. 3 (May/June 1999)
Code
PPO5
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Treatment Patterns and Guidelines
Disease
Multiple Diseases